Navigation Links
Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
Date:4/24/2008

- Findings Published in the British Journal of Hematology -

FREMONT, Calif., April 24 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML) today reported findings from an Ohio State University (OSU) clinical study that indicated that a surface-enhanced laser desorption/ionization time of flight (SELDI-TOF)-based thrombotic thrombocytopenic purpura (TTP) diagnostic test could be used to help estimate the risk of TTP relapses during clinical remission. OSU currently offers the TTP test as a laboratory developed test, based on an exclusive licensing agreement with Vermillion, and for which Vermillion sells OSU supplies and laboratory reagents.

The data -- published recently in the online edition of the British Journal of Haematology -- indicate that use of the test may provide a novel screening strategy to identify patients who may benefit from prophylactic treatment to help prevent relapse of this serious blood disorder. TTP is caused by a deficient activity of the enzyme ADAMTS13, which leads to platelet clumping, red blood cell destruction, and, in serious cases, to neurological abnormalities and renal failure.

"TTP is a life-threatening disease that affects thousands of people each year. The disease is characterized by frequent recurrences, with approximately half of all patients experiencing relapses," said Haifeng M. Wu, M.D., lead investigator of the study and Assistant Professor of Pathology and Medicine and Director of the Clinical Coagulation Laboratory at OSU Medical Center. "The SELDI-TOF technology was instrumental in improving sensitivity for extremely low levels of ADAMTS13, which may be used to help identify patients who could be candidates for prophylactic treatment based upon their increased ri
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
6. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
7. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
8. Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges
9. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 Eli Lilly and Company ... the second quarter of 2015 on Thursday, July 23, 2015. ... with the investment community and media to further detail the ... at 9 a.m. EDT. Investors, media and the general public ... a link that will be posted on Lilly,s website at ...
(Date:7/1/2015)... ISELIN, N.J. , July 1, 2015 /PRNewswire/ ... medical device company focused on non-invasive continuous glucose ... of its new and completely re-designed corporate website ... and intuitive access to Echo,s technology and enhances ... The new website better communicates to prospective ...
(Date:7/1/2015)... 2015 Dynatronics Corporation (the "Company") (NASDAQ: ... rehabilitation and physical therapy products, announced today that ... led by affiliates of Prettybrook Partners LLC (collectively, ... the healthcare industry. The financing provides Dynatronics with ... potential strategic acquisitions.  "We enthusiastically ...
Breaking Medicine Technology:Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... Mass., May 19, 2011 Alere Inc. (NYSE: ALR ... their health at home through the merger of rapid diagnostics and ... its Series B Convertible Perpetual Preferred Stock (NYSE: ALR ... Series B stock in an amount per share equal to the ...
... a segment of BD (Becton, Dickinson and Company) (NYSE: ... BD MAX™ for use as an open system. ... molecular system designed to perform a broad range of molecular ... but also user-defined protocols and life science research applications. The ...
Cached Medicine Technology:BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases 2BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases 3
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the leader in ... the release and publication of their newest offering to complement the existing line ... , Designed in support of coverage for the full spectrum of Semi ...
(Date:7/1/2015)... ... ... A June 19th article by the Associated Press discussed a recent announcement by ... of medical care, specifically for seniors. Medicare recently completed the first year of a three ... Medicare’s chief medical officer, Dr. Patrick Conway said that “If we can keep people as ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... Biomedical Sciences at Georgia State University and a Georgia Research Alliance Eminent Scholar ... develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant from the National ...
(Date:7/1/2015)... ... July 01, 2015 , ... For decades, researchers in ... histones, remain constant in the brain, never changing after development in the womb. Now, ... are steadily replaced in brain cells throughout life – a process which helps to ...
(Date:7/1/2015)... Allen, TX (PRWEB) , ... July 01, 2015 ... ... designed for retail, long term care, specialty, combo, and compounding pharmacy operations, announces ... upcoming attendance to the Cardinal Health RBC event at the Venetian ...
Breaking Medicine News(10 mins):Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 2Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 3Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4
... 28 Shazaaam! LLC, an integrated,marketing communications ... Public Relations and Marketing Communications Agency of,Record ... will provide social marketing, proactive and reactive,blogging, ... enhance,ETC,s branding and visibility among its target ...
... study from Rice University chemists and scientists in the ... based on carbon nanotubes can help prevent people from ... new study was commissioned after preliminary tests found the ... reducing the effects of acute radiation injury than the ...
... Senior Writer Daniel Gross looks at,the signs that are ... not,that will pull the rest of world down with ... economic activity lasting more than a few months,and because ... declared until long after they start. In short, the ...
... of researchers in Australia, the United Kingdom and the ... from the mother to the next generation in a ... in Nature Genetics*, shows for the first time how ... failure and epilepsy are passed from mother to offspring. ...
... rhinitis, conjunctivitis or insect bites , , SATURDAY, Jan. ... asthma, rhinitis, conjunctivitis or stinging insect allergies, you ... also known as immunotherapy. , That,s the recommendation ... Immunology. , "Immunotherapy is a form of treatment ...
... Society of Plastic Surgeons (ASPS) today addressed concerns,regarding ... events following,a recent petition from a consumer group., ... U.S. Food and Drug,Administration (FDA) implement labeling changes ... one million people have been treated with BOTOX ...
Cached Medicine News:Health News:Shazaaam! Named PR Agency of Record for Enuresis Treatment Center 2Health News:Feds fund study of drug that may prevent radiation injury 2Health News:NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28) 2Health News:NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28) 3Health News:NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28) 4Health News:NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28) 5Health News:In silico modeling helps predict severity of mitochondrial disease 2Health News:Allergy Shots Are Effective Treatment for Symptoms 2Health News:ASPS Addresses Concerns Regarding BOTOX Treatments 2
The WatchMate LC model is a cost-effective solution for monitoring a single exit, and provides local notification of an alarm....
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
... RoamAlert Integrity system builds on the ... door controllers in the system are ... a standard Windows® operating system, which ... of a personal computer, RoamAlert Integrity ...
... Radianse indoor positioning solution ... of where and when ... flow through care processes. ... provides intelligence that hospitals ...
Medicine Products: